Imagable 4T1 model for the study of late stage breast cancer. - Wikidata - awgldk - TriplyDB

Imagable 4T1 model for the study of late stage breast cancer.

Imagable 4T1 model for the study of late stage breast cancer.

http://www.wikidata.org/entity/Q33358981

about

Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation A comparative histopathological study of systemic candidiasis in association with experimentally induced breast cancer Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression RNA Relics and Origin of Life Osteolytica: An automated image analysis software package that rapidly measures cancer-induced osteolytic lesions in in vivo models with greater reproducibility compared to other commonly used methods Cytocidal activities of topoisomerase 1 inhibitors and 5-azacytidine against pheochromocytoma/paraganglioma cells in primary human tumor cultures and mouse cell lines Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model Adenosine A2B receptor blockade slows growth of bladder and breast tumors.Remnant living cells that escape cell loss in late-stage tumors exhibit cancer stem cell-like characteristics miR-200-containing extracellular vesicles promote breast cancer cell metastasis.A Eu(II)-Containing Cryptate as a Redox Sensor in Magnetic Resonance Imaging of Living Tissue.RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth and induces apoptosis in mouse breast cancer in vitro and in vivo.Non-invasive detection of a small number of bioluminescent cancer cells in vivo Efficacy of polyMPC-DOX prodrugs in 4T1 tumor-bearing mice Small-sized polymeric micelles incorporating docetaxel suppress distant metastases in the clinically-relevant 4T1 mouse breast cancer model Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression Pretubulysin: a new option for the treatment of metastatic cancer.Remote reprogramming of hepatic circadian transcriptome by breast cancer.Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer.Targeting breast tumors with pH (low) insertion peptides Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion.Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Positron Emission Tomography Imaging Agent Detection and quantitation of circulating tumor cell dynamics by bioluminescence imaging in an orthotopic mammary carcinoma model.Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan Differential mechanical response of mesenchymal stem cells and fibroblasts to tumor-secreted soluble factors An improved syngeneic orthotopic murine model of human breast cancer progression Multi-dye theranostic nanoparticle platform for bioimaging and cancer therapy Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype.Kinetics of host cell recruitment during dissemination of diffuse malignant peritoneal mesothelioma.Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model A methyl methacrylate-HEMA-CL(n) copolymerization investigation: from kinetics to bioapplications.Icaritin synergistically enhances the radiosensitivity of 4T1 breast cancer cells.Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles.Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.Detection of enzyme activity in orthotopic murine breast cancer by fluorescence lifetime imaging using a fluorescence resonance energy transfer-based molecular probe

P2860

Q21261284-D7E25096-1529-4103-92CE-8463CB0F0609 Q24605538-F2B71A2C-049F-4560-AF85-A65D31A33527 Q27001081-41851F3C-4859-4986-A0F9-A402D31C6CC9 Q27325140-C51E1A25-DA20-40B7-A82D-6B35D7619AAC Q27490853-5FCF3E85-CBE7-4BC5-BFA7-C703AA9256A3 Q28364664-8BF1D524-2784-49E2-8F8E-DE75D1A55CD3 Q28539650-54028BB3-12CD-457D-8A38-FFFF871E07A4 Q28547327-16C92FD6-A72D-4802-8A94-158555906DAF Q30416420-C34D21F4-E721-44AF-B6C4-76219066AA73 Q30526491-4D798B07-C8F8-4EBD-8C00-42561D85024F Q30624403-4C829507-37A9-4464-B169-E114F025F4F9 Q31000314-13C71FA8-83E1-48A9-93DD-C2BEBD8A6CC0 Q32184965-C6647ED8-D59E-45F2-89F6-2A4CD3363D5B Q33534682-2A54CC87-F6EC-49D8-8FBE-DDD7B572D06A Q33598779-BECABA12-E15E-48CB-B979-36336FD3E8D5 Q33622043-8AEC113C-33C5-48FC-8510-AEC47DDCE496 Q33667156-705795B5-1346-4645-A5B8-679DB8693EC6 Q33688434-DB70D877-36AF-4320-A80A-452BB610C13A Q33695171-E7CDC424-FA49-4ED5-86DD-729FCA4C7C15 Q33798291-6EC5E9A3-2842-4D3C-830B-776496FEAFB2 Q33905819-59B6CBBC-A447-4984-BB50-689BAD929789 Q34011123-DE4F804C-7C37-4A29-A216-1E65A8378E92 Q34065630-E064C632-C8EA-43F3-A0E8-BE42ABD31BC9 Q34111208-B1124FB5-259E-4888-BB7F-543C5CC4D7F4 Q34134704-CF405AD2-2D50-498B-B534-388F6E6765F5 Q34145464-71855A4D-B0A0-46E2-8227-B18F80E60DF6 Q34206151-3E9D1736-0E62-4E08-9BD5-E1470D77A74F Q34250295-FBE25785-9C8B-4081-A6D5-13749125B286 Q34304891-9D402E73-1AFD-4EA3-A942-2F5FDE2EF035 Q34393640-51B97785-94B6-489D-8588-E4E7A5819589 Q34411361-8223C919-1F04-4FBC-A9FD-AB39D6395613 Q34440549-24A0234F-9D7F-4677-8440-F335A4C5DFBF Q34618985-B49C1D60-2A7C-4B97-9BAB-305D4E0AE35D Q34755674-BC7FCD52-4BBA-48A6-B9EC-F34D64292920 Q34844413-D9C010DF-9D82-4C0D-9239-78AEDAE61F14 Q34970960-46090A49-F5DB-498C-9F2D-B3CFE6651234 Q35021021-0954A732-9AA0-4BF5-9B5D-E9F069632A7E Q35023993-3D321730-0E26-4CAE-945B-35F514A2E001 Q35034709-3C6CCE19-F50C-439B-9897-5B97F91A44C1 Q35112547-1EB78489-B938-4EFD-905D-2C496B9CF770

P2860

Imagable 4T1 model for the study of late stage breast cancer.

http://www.wikidata.org/entity/Q33358981

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Imagable 4T1 model for the study of late stage breast cancer.

@ast

Imagable 4T1 model for the study of late stage breast cancer.

@en

type

label

Imagable 4T1 model for the study of late stage breast cancer.

@ast

Imagable 4T1 model for the study of late stage breast cancer.

@en

prefLabel

Imagable 4T1 model for the study of late stage breast cancer.

@ast

Imagable 4T1 model for the study of late stage breast cancer.

@en

P1433

Q33358981-DAAE5873-B7D6-4DDC-9441-BE7DE8A7390E

P1476

Q33358981-966CFBAF-35D9-4F2E-B23E-C277DBD72572

P2093

Q33358981-33965C94-B8E9-428E-8984-468E216A0A98

Q33358981-58BE3F33-D38A-4BA8-A9B4-004498AFDF8A

Q33358981-9E8E4B50-7F1B-4AF4-B015-47B00580590B

Q33358981-F708EE41-13DD-4FDA-A313-26AFDA6534E5

P2860

Q33358981-1D57B028-DC41-4408-83FE-29AF06593634

Q33358981-2627275B-A148-4F5B-BC45-E6C84F31A25B

Q33358981-30309B81-3CF4-4C92-AEF7-56A0014B7EA3

Q33358981-38B08C04-C2A1-4258-B1A7-3D699312047F

Q33358981-3B91DD6E-D292-40E4-84CD-792EE4A28DAE

Q33358981-40387729-D234-45B7-802C-AFAF8722EB91

Q33358981-497606EA-1975-4661-B4F1-1BB49EEC93AB

Q33358981-51A248AA-7A9B-4426-A733-716D68856781

Q33358981-573A8675-4143-4CEF-8FEB-F241D98998BF

Q33358981-5796F93F-D825-411C-8B6E-A25E62FD3B5A

P2888

Q33358981-1C901E5E-518B-4D6F-8970-1D487F0A80D8

P304

Q33358981-7CB10EB0-2C0C-4B19-9FC3-B3176DD19CF2

P31

Q33358981-C9ADA325-1D93-4BED-86F1-4375023460C5

P356

Q33358981-E702D1C8-D64B-495A-ADB8-B1AF752B0302

P407

Q33358981-32C560C3-5F98-4E1E-81EF-F0C439232538

P478

Q33358981-D6F8CD52-0140-4C9B-942D-1FFC883D649E

P577

Q33358981-73807D7E-F389-4C18-9499-F684520645BF

P5875

Q33358981-79F8E02D-7F0A-486F-9C1F-BF03C5BEF786

P6179

Q33358981-9E616B07-A40C-42BF-8A9C-3BFEAE499C38

P698

Q33358981-02AABF3B-D11F-48DE-8FED-DF0DDFCCE09D

P932

Q33358981-80365D52-70A3-4184-9BAF-BF248D57F054

P356

1471-2407-8-228

P1433

P1476

Imagable 4T1 model for the study of late stage breast cancer.

@en

P2093

G Gary Sahagian

http://www.w3.org/2001/XMLSchema#string

Joseph Alroy

http://www.w3.org/2001/XMLSchema#string

Kai Tao

http://www.w3.org/2001/XMLSchema#string

Min Fang

http://www.w3.org/2001/XMLSchema#string

P2860

Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils

Human and bovine granulocyte chemotactic protein-2: complete amino acid sequence and functional characterization as chemokines

Fragments of extracellular matrix as mediators of inflammation

Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer

Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells

Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.

Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma.

MCP-1 and RANTES are mediators of acute and chronic inflammation.

Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

P2888

1471-2407-8-228

P304

228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-8-228

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23160121

http://www.w3.org/2001/XMLSchema#string

P6179

1051907730

http://www.w3.org/2001/XMLSchema#string

P698

18691423

http://www.w3.org/2001/XMLSchema#string

P932

2529338

http://www.w3.org/2001/XMLSchema#string